about
Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriersIdentification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagenEBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.Emerging Roles of the Mitogen and Stress Activated Kinases MSK1 and MSK2Historical review of the causes of cancerInfectious MononucleosisThe criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiationCellular immunotherapy for pediatric solid tumorsEpstein-Barr virus antibodies and the risk of associated malignancies: review of the literatureNasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentationDiagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia.Role of the ubiquitin system and tumor viruses in AIDS-related cancer.OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation.Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinomaSequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese.Knowledge of general practitioners about nasopharyngeal cancer at the Puskesmas in Yogyakarta, Indonesia.Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States.Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan.Dissecting the regulation of EBV's BART miRNAs in carcinomas.Identification of a novel methylated gene in nasopharyngeal carcinoma: TTC40EBV latency types adopt alternative chromatin conformations.Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiationEvaluation and integration of genetic signature for prediction risk of nasopharyngeal carcinoma in Southern ChinaIn nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.Epstein-Barr virus Latent Membrane Protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathway.Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma.Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19.Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma.Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter.Unusual cancer in primary Sjögren syndromeNF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1Human tumor virus utilizes exosomes for intercellular communication.Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancersEpstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.
P2860
Q24561854-43323FE2-BB62-4EE5-AEE4-A9FF630BB340Q24633907-B204AC29-D82B-41F5-BEE0-D483D511B33AQ24804219-D498BE42-080E-45AD-A1C8-9BB532BDEFC2Q26744783-40A5AE4D-BCA4-4E45-B2F9-E83DDC99871FQ26767036-AFC5D3E6-9EB8-414B-8B83-2503C5D4671FQ26783692-7E4C2D77-D372-4AE3-9DBA-05124D4CC805Q26853527-B7988702-52B1-48D3-B71E-D549A80054E4Q27014912-91036C10-B6A2-41AB-999B-92B2274BE799Q27021572-7802312D-3EEC-4D8F-97B4-686D878C1B10Q28680671-6BDE79C3-3072-4412-8D8A-480A4FBA9C98Q33218405-748E051F-5AEE-4300-92B0-DAA4A3209477Q33307881-1399B9D1-E7A9-4BF3-A340-158CE126FFFDQ33361612-FCF8C842-CC34-4E39-8EBC-9ED878B686B1Q33373662-87B3A6D5-F14E-44FE-BECD-6E36CE3DBD5EQ33567401-196E11B6-1878-4C66-B799-7FC55E9B0A69Q33638951-F18D5AB7-74D5-4481-9235-971330191741Q33655046-E1C92373-A2FA-43C7-AF80-0D31FBE95A13Q33724843-402B4388-7D04-489C-BCF8-5A545A0F3E7DQ33743665-05D6A03C-0926-466D-9EA6-266E6CFAD155Q33750698-C8B58A2D-0D65-457D-AEDF-9DD179AF551BQ33759475-FB1DD50F-103A-481D-8D32-BA864C94EBB7Q33760249-8511F592-09AE-49AA-9033-F90F1F49ED95Q33847952-30F42697-AD4A-46C0-AA59-50D95C57B31EQ33892295-F194FB64-EBF0-43C0-B26C-9726B9344B6CQ33912110-0048872B-66A6-40D4-9024-6AB46B794628Q33987454-4625F226-AB76-4B5C-8EBB-5714253DA355Q34029669-F6B286B3-A55F-4C51-89A1-F25F1EB89335Q34081186-9EDB7AEB-9A5E-480E-BC3E-4D4F5B234FE0Q34092709-1EE21CC8-0AFC-4015-9E96-9EDB9377B4BAQ34106993-63D1AF98-511C-4CCD-8D1A-7756425C748BQ34221714-0D836B7F-4AF1-4061-B15D-DC9DE7A4C195Q34237606-A305EF87-247E-4EB4-AA82-25377C04710CQ34242449-E673AD87-4B05-4A04-8036-47F38FE28F21Q34261764-579760BE-75D6-4A93-A41C-8F41F9C8DA0FQ34315482-36E93240-6EF1-4464-9B86-C878240E9844Q34337769-C3698190-9074-4485-94DA-A9DCA4BAF64DQ34352790-EC43819B-F9FE-4FF5-8AE4-979CC16E0AE2Q34377767-18F4DFC9-A543-43D7-97D6-DF620333B020Q34535924-660D8EBF-0446-405F-B929-29F46117C254Q34586675-92D30376-54A9-48C2-A759-EED116A506A6
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Epstein-Barr virus in the pathogenesis of NPC.
@ast
Epstein-Barr virus in the pathogenesis of NPC.
@en
type
label
Epstein-Barr virus in the pathogenesis of NPC.
@ast
Epstein-Barr virus in the pathogenesis of NPC.
@en
prefLabel
Epstein-Barr virus in the pathogenesis of NPC.
@ast
Epstein-Barr virus in the pathogenesis of NPC.
@en
P1476
Epstein-Barr virus in the pathogenesis of NPC.
@en
P2093
Nancy Raab-Traub
P304
P356
10.1016/S1044579X0200086X
P577
2002-12-01T00:00:00Z